Skip to main content
OpenTrials

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

453 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Completed

An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis

NCT01633372

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Birmingham Hematology Oncology Associates, LLC Birmingham, Alabama, United States
  • Mayo Clinic, Arizona Scottsdale, Arizona, United States
  • UCLA Hematology & Oncology Los Angeles, California, United States
  • Emory University Atlanta, Georgia, United States
View all 22 locations
View Trial Details
Completed

Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis

NCT01814475

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +8 more
Locations
  • Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy
  • Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy
  • Divisione di Ematologia - Ospedali Papa Giovanni XXIII Bergamo, Italy
  • AO Spedali Civili di Brescia- USD - TMO Adulti Brescia, Italy
View all 21 locations
View Trial Details
Completed

Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis

NCT01433445

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Villejuif, France
  • Novartis Investigative Site Magdeburg, Germany
  • Novartis Investigative Site Mainz, Germany
View Trial Details
Completed

PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

NCT03065400

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Chronic Phase Myelofibrosis, +9 more
Locations
  • Harvard Medical School Massachusetts General Hospital Boston, Massachusetts, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Montefiore Medical Center Division of Hematology, Department of Oncology The Bronx, New York, United States
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details

Related conditions